KUALA LUMPUR: Leading fertility care specialist Alpha IVF Group Bhd (Alpha IVF) says it remains focused on both domestic and international expansion.
Domestically, the company is progressing with its fourth specialist centre, Alhaya Fertility Centre (Alhaya-KL) here.
"The new centre is aimed at attracting more Muslim patients locally and internationally, as Alhaya-KL will be positioned as a Muslim-friendly centre," it said.
The centre, upon receiving approval from the Ministry Of Health, commenced operations on April 8.
Aside from that, Alpha IVF said it is actively working on setting up a specialist centre in Bali as part of its broader regional expansion strategy.
Last year, Alpha IVF entered into an agreement with PT Hotel Indonesia Natour to reserve the leasing of a plot of land with a total land area of 6,000 square metres in the health and tourism special economic zone in Bali.
Both parties have commenced negotiations on the terms and conditions of the definitive agreement.
The specialist centre in Bali will be another overseas centre for Alpha IVF following the successful setting up of the Singapore centre in November 2019.
Alpha IVF posted a net profit attributable to shareholders (Patmi) of RM38.9 million on group revenue of RM120.8 million for the nine months ended February 29 2024 (9M24).
There is no comparison to the corresponding period of the previous year, because Alpha IVF was listed on the ACE market of Bursa Malaysia on March 22 after the closing of 9M24.
In the previous financial year ended May 31 2023, the company recorded RM137.5 million revenue and RM53.2 million Patmi.
Alpha IVF managing director Datuk Dr Colin Lee Soon Soo said the growing acceptance of fertility solutions, together with its commitment to providing high-quality care, have allowed it to expand its patient base and generate sustainable growth.
"Furthermore, we are seeing an increase in demand from overseas patients returning to Malaysia, driven by resurgence of medical tourism and reopening of borders.
"This upsurge reflects patients' confidence in our services and the reputation of Malaysia as a hub for reproductive treatments," he said.
The company is optimistic about its prospects and ability to sustain growth, especially with the upward trajectory of patients choosing Malaysia for reproductive treatments.
"To this end, we will leverage on our expertise, cutting-edge technology, and in-house system of systems to meet the evolving needs of patients seeking reproductive treatment and continue our aspirations of empowering individuals and couples on their path to parenthood," it said.
